Itafos Inc. announced that it has entered into a monoammonium phosphate sales agreement with J. R. Simplot Company. Pursuant to the MAP Offtake Agreement, Itafos will sell J.R. Simplot Company 100% of the monoammonium phosphate ("MAP") produced by the Company at its manufacturing facility located in Conda, Idaho during the term of the MAP Offtake Agreement which will commence on January 1, 2024, with a term of five (5) years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 CAD | +1.53% | +0.76% | +1.53% |
12:00am | Itafos Inc. Announces Results of Updated Itafos Conda Technical Report | CI |
Apr. 15 | RBC Capital Markets Gives Nutrien Outperform Rating, US$70 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.53% | 186M | |
+1.67% | 15.17B | |
-14.18% | 15.06B | |
+6.58% | 12.61B | |
-13.63% | 9.92B | |
-11.43% | 7.34B | |
-.--% | 7.21B | |
-3.30% | 4.25B | |
-27.17% | 2.43B | |
+2.63% | 2.07B |
- Stock Market
- Equities
- IFOS Stock
- News Itafos Inc.
- Itafos Inc. Enters into Monoammonium Phosphate Sales Agreement with J. R. Simplot Company